SG Americas Securities
APYX icon

SG Americas Securities’s Apyx Medical APYX Stock Holding History

SG Americas Securities’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,680
Closed -$148K – 3364
2021
Q3 		$148K Buy
+10,680
New +$112K ﹤0.01% 3444
2020
Q3 		– Sell
-18,315
Closed -$102K – 2692
2020
Q2 		$102K Buy
18,315
+6,423
+54% +$26.7K ﹤0.01% 3354
2020
Q1 		$43K Buy
+11,892
New +$79.8K ﹤0.01% 3196

Other funds holding APYX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return

SG Americas Securities's APYX Position: Q4 2021 in Review

SG Americas Securities sold out of Apyx Medical (APYX) in Q4 2021, closing a stake of 10,680 shares — an estimated $148K sold.

SG Americas Securities first reported a position in APYX in Q1 2020 and held it in 3 quarters. The position peaked at $148K in Q3 2021. 75 funds tracked by Wall St. Rank hold APYX as of Q4 2021.

  • SG Americas Securities reported no remaining Apyx Medical position as of Q4 2021 after selling out during the quarter.
  • SG Americas Securities sold 10,680 Apyx Medical shares in Q4 2021, an estimated $148K.
  • SG Americas Securities first reported a position in Apyx Medical in Q1 2020 and held it in 3 quarters.
  • SG Americas Securities's Apyx Medical position peaked at $148K in Q3 2021.
  • 75 funds tracked by Wall St. Rank held Apyx Medical as of Q4 2021.

Based on SG Americas Securities's 13F filing for Q4 2021, filed 7 Feb 2022.